Letter: Leukaemia children

Kenneth Campbell
Tuesday 01 December 1998 00:02 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Sir: The Leukaemia Research Fund has been greatly saddened to learn of the death of Georgina Horlick. Despite all the pressures on her time, Georgina's mother, Nicola, has given selfless and invaluable support to the fundraising efforts of the Leukaemia Research Fund.

It is unfortunate that reports in your paper and in The Independent on Sunday have contained errors of fact which may unnecessarily alarm the parents of other children with leukaemia. The Independent on Sunday has stated that about 1,200 children a year are diagnosed with leukaemia. Happily the true figure is about 420 cases a year.

More seriously, the impression is given (report, 30 November) that within the last five years bone-marrow transplants have become the treatment of choice for childhood leukaemia. This is not the case. Some two-thirds to three-quarters of all children with acute leukaemia will have an excellent response to chemotherapy. The relatively more toxic and dangerous bone- marrow transplant approach is reserved for children identified as having high-risk leukaemia or for children, like Georgina, who have relapsed. The article further implies that long-term follow up treatment is a new approach, whereas this was introduced about 30 years ago.

There is little or no evidence to support the assertion that every last leukaemia cell must be destroyed for treatment to be successful. This is the subject of ongoing research but there is historical evidence to suggest that cure is not dependent on a strategy of total annihilation of all leukaemia cells.

Although there has been major progress in treatment of childhood leukaemia, there is much work still to be done. Education of the public has a valuable part to play, but it is vital that the information is timely and accurate.

KENNETH CAMPBELL

Leukaemia Research Fund

London WC1

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in